Monday, April 1, 2019

Cipla signs $22 mn pact with Pulmatrix Inc for new asthma drug

Cipla signs $22 mn pact with Pulmatrix Inc for new asthma drug Pulmazole is an inhaled anti-fungal formulation of itraconazole aimed at treating allergic bronchopulmonary aspergillosis (ABPA) in asthma patients.

from Moneycontrol Business News https://ift.tt/2TNWWab

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...